首页 | 本学科首页   官方微博 | 高级检索  
检索        

胰岛素抵抗肝癌细胞IGF-1R/NF-κB表达及多药耐药机制研究
引用本文:王以浪,印 滇,杨 莉,张 亮,姚登福.胰岛素抵抗肝癌细胞IGF-1R/NF-κB表达及多药耐药机制研究[J].实用肝脏病杂志,2016,19(6):704-708.
作者姓名:王以浪  印 滇  杨 莉  张 亮  姚登福
作者单位:226001 江苏省南通市第一人民医院肿瘤科(王以浪,印滇,杨莉,张亮);南通大学附属医院临床研究中心(姚登福)
基金项目:南通市卫生局青年医学人才科研基金项目(编号:WQ2014005)
摘    要:目的 探讨胰岛素抵抗(IR)肝癌细胞胰岛素样生长因子1受体(IGF-1R)和核因子-κB(NF-κB)表达变化及多药耐药(MDR)发生机制。方法 采用高浓度胰岛素诱导人肝癌细胞(HepG2和HepG2.2.15)建立胰岛素抵抗(IR)细胞模型。采用Western blot 法检测胰岛素受体(InsR)、IGF-1R、NF-κB 和 P-糖蛋白(P-gp)表达变化。使用流式细胞仪(Annexin V-FITC法)检测阿霉素对细胞凋亡的影响。结果 分别用100 nmol/L 和 1 000 nmol/L 胰岛素培养 HepG2 和 HepG2.2.15 细胞 48 h,成功建立 IR 肝癌细胞模型;IR 肝癌细胞 IGF-1R、NF-κB、P-gp 表达上调,而InsR 表达下调;应用 25μg/mL 阿霉素作用细胞 24 h 后,IR-HepG2 细胞组凋亡率(31.1%±1.9%)显著低于HepG2 细胞组【(49.7%±2.2%),P<0.01】,IR-HepG2.2.15细胞凋亡率【(20.1±1.7) %】显著低于 HepG2.2.15 细胞【(33.8±1.8)%,P<0.01】;HepG2.2.15 和 IR-HepG2.2.15 细胞凋亡率分别较 HepG2 和 IR-HepG2 细胞显著降低(P<0.01)。结论 IGF-1R/NF-κB/P-gp 过表达可能介导 IR 肝癌细胞对阿霉素的多药耐药。

关 键 词:HepG2细胞  胰岛素抵抗  胰岛素样生长因子1受体  核因子-κB  P糖蛋白  多药耐药  
收稿时间:2016-06-20

Expression of IGF-1R/NF-kappa B and multi-drug resistance in insulin resistance-HepG2 and HepG2.2.15 cells in vitro
Wang Yilang,Yin Dian,Yang Li,et al..Expression of IGF-1R/NF-kappa B and multi-drug resistance in insulin resistance-HepG2 and HepG2.2.15 cells in vitro[J].Journal of Clinical Hepatology,2016,19(6):704-708.
Authors:Wang Yilang  Yin Dian  Yang Li  
Institution:Department of Oncology,Research Center of Clinical Medicine,First People’s Hospital Affiliated to Nantong University,Nantong,226001,Jiangsu Province,China
Abstract:Objective To investigate the expression of insulin-like growth factor 1 receptor(IGF-1R),nuclear factor-κB(NF-κB) and the mechanism of multi-drug resistance(MDR) in insulin resistance(IR)- hepatoma cells in vitro. Methods The human hepatoma cells(HepG2 and HepG2.2.15) were induced by high concentration of insulin to establish a insulin resistance model. The expression of insulin receptor (InsR),IGF-1R,NF kappa B,P glycoprotein(P-gp) were detected by Western bloting and the effect of adriamycin on cell apoptosis were detected by flow cytometry(annexin V-FITC). Results IR model of hepatoma cells were established successfully by subjecting the HepG2 and HepG2.2.15 cells to 100 nmol/L and 1 000 n mol/L insulin respectively for 48 hours. The expression of IGF-1R,NF-kappa B and P-gp were up-regulated in IR hepatoma cells,while the InsR expression was down-regulated;After treatment of the two cells with 25 μg/ml doxorubicin for 24 hours,the apoptosis rate of IR-HpeG 2 cells (31.1% ±1.9%) was significantly lower than HepG2 cells (49.7±2.2)%,P<0.01],and the apoptosis rate of IR-HepG2.2.15 cells(20.1±1.7)% was significantly lower than HepG2.2.15 cells(33.8±1.8)%,P<0.01];The apoptotic rates of HepG2.2.15 or IR-HepG2.2.15 cells were significantly lower than HepG2 or IR-HepG2 cells(P<0.01),respectively. Conclusion The expression of IGF-1R, NF-kappa B and P-gp are up-regulated in IR-hepatoma cells,which might induce the MDR to adriamycin.
Keywords:HepG2 cells  Insulin resistance  Insulin-like growth factor I receptor  NF-kappa B  P-glycoprotein  Multi-drug resistance  
本文献已被 CNKI 等数据库收录!
点击此处可从《实用肝脏病杂志》浏览原始摘要信息
点击此处可从《实用肝脏病杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号